Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friedrich Foerster

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Cancers|October 13, 2021
Immunonutritive Scoring for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Evaluation of the CALLY IndexLukas Müller, Felix Hahn, Aline Mähringer-Kunz, et al.
Journal of Clinical Medicine|August 27, 2021
Liver Resection for Intrahepatic Cholangiocarcinoma-Single-Center Experience with 286 Patients Undergoing Surgical Exploration over a Thirteen Year PeriodHauke Lang, Janine Baumgart, Stefan Heinrich, et al.
Journal of Clinical Medicine|July 2, 2021
The Addition of Transarterial Chemoembolization to Palliative Chemotherapy Extends Survival in Intrahepatic CholangiocarcinomaSimon Johannes Gairing, Felix Thol, Lukas Müller, et al.
Plos One|August 22, 2025
Bone mineral density predicts survival in patients with hepatocellular carcinoma and portal vein tumor thrombosisLukas Müller, Roman Kloeckner, Lorena Heim, et al.
Hepatology Communications|February 24, 2025
MCAM is a prognostic biomarker in patients with liver cirrhosis and HCCEva Stockinger, Hendrik Luxenburger, Dominik Bettinger, et al.
United European Gastroenterology Journal|December 17, 2021
Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolizationLukas Müller, Felix Hahn, Aline Mähringer-Kunz, et al.
Zeitschrift Fur Gastroenterologie|November 15, 2022
Bevacizumab in combination with octreotide rescues a patient with liver cirrhosis, GAVE syndrome and refractory hemorrhage - a case reportSimon Johannes Gairing, Eva Maria Schleicher, Lukas Müller, et al.
Gastroenterology|April 7, 2020
Wheat Consumption Aggravates Colitis in Mice via Amylase Trypsin Inhibitor-mediated DysbiosisGeethanjali Pickert, Stefan Wirtz, Johannes Matzner, et al.
JHEP Reports : Innovation in Hepatology|February 10, 2022
Outcomes in patients receiving palliative chemotherapy for advanced biliary tract cancerFelix Thol, Simon Johannes Gairing, Carolin Czauderna, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2022
pH-degradable, bisphosphonate-loaded nanogels attenuate liver fibrosis by repolarization of M2-type macrophagesLeonard Kaps, Anne Huppertsberg, Niklas Choteschovsky, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Cancers|October 13, 2021
Immunonutritive Scoring for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Evaluation of the CALLY IndexLukas Müller, Felix Hahn, Aline Mähringer-Kunz, et al.
Journal of Clinical Medicine|August 27, 2021
Liver Resection for Intrahepatic Cholangiocarcinoma-Single-Center Experience with 286 Patients Undergoing Surgical Exploration over a Thirteen Year PeriodHauke Lang, Janine Baumgart, Stefan Heinrich, et al.
Journal of Clinical Medicine|July 2, 2021
The Addition of Transarterial Chemoembolization to Palliative Chemotherapy Extends Survival in Intrahepatic CholangiocarcinomaSimon Johannes Gairing, Felix Thol, Lukas Müller, et al.
Plos One|August 22, 2025
Bone mineral density predicts survival in patients with hepatocellular carcinoma and portal vein tumor thrombosisLukas Müller, Roman Kloeckner, Lorena Heim, et al.
Hepatology Communications|February 24, 2025
MCAM is a prognostic biomarker in patients with liver cirrhosis and HCCEva Stockinger, Hendrik Luxenburger, Dominik Bettinger, et al.
United European Gastroenterology Journal|December 17, 2021
Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolizationLukas Müller, Felix Hahn, Aline Mähringer-Kunz, et al.
Zeitschrift Fur Gastroenterologie|November 15, 2022
Bevacizumab in combination with octreotide rescues a patient with liver cirrhosis, GAVE syndrome and refractory hemorrhage - a case reportSimon Johannes Gairing, Eva Maria Schleicher, Lukas Müller, et al.
Gastroenterology|April 7, 2020
Wheat Consumption Aggravates Colitis in Mice via Amylase Trypsin Inhibitor-mediated DysbiosisGeethanjali Pickert, Stefan Wirtz, Johannes Matzner, et al.
JHEP Reports : Innovation in Hepatology|February 10, 2022
Outcomes in patients receiving palliative chemotherapy for advanced biliary tract cancerFelix Thol, Simon Johannes Gairing, Carolin Czauderna, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2022
pH-degradable, bisphosphonate-loaded nanogels attenuate liver fibrosis by repolarization of M2-type macrophagesLeonard Kaps, Anne Huppertsberg, Niklas Choteschovsky, et al.
Pageof 6